|
WDC
|
Technology |
Summit Insights |
Downgrade
|
Buy
→
Hold
|
—
|
$178.9B
|
$519.17
|
-17.4%
|
-13.0%
|
-3.8%
|
+0.9%
|
-0.1%
|
+3.7%
|
|
APP
|
Technology |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
$385
|
$140.4B
|
$417.80
|
-19.0%
|
-19.7%
|
+3.3%
|
-2.2%
|
-6.0%
|
-4.7%
|
|
APP
|
Technology |
Wells Fargo |
Downgrade
|
Overweight
→
Equal Weight
|
$357
|
$140.4B
|
$417.80
|
-19.0%
|
-19.7%
|
+3.3%
|
-2.2%
|
-6.0%
|
-4.7%
|
|
PSX
|
Energy |
TD Cowen |
Reiterates
|
Buy
|
$255
|
$81.2B
|
$202.55
|
+3.2%
|
+1.5%
|
-0.8%
|
+5.7%
|
+4.1%
|
+0.5%
|
|
FMX
|
Consumer Defensive |
UBS |
Downgrade
|
Buy
→
Neutral
|
$139
|
$42.4B
|
$124.37
|
-1.0%
|
-1.8%
|
+0.2%
|
-2.1%
|
-1.4%
|
-0.6%
|
|
ROP
|
Industrials |
ArgusD |
Upgrade
|
Hold
→
Buy
|
$450
|
$39.8B
|
$394.53
|
+0.8%
|
+0.6%
|
+1.3%
|
+0.4%
|
-1.1%
|
-1.1%
|
|
TPR
|
Consumer Cyclical |
Telsey Advisory Group |
Reiterates
|
Outperform
|
$175
|
$32.2B
|
$159.16
|
+1.1%
|
+1.8%
|
+0.2%
|
+1.5%
|
-2.6%
|
-4.2%
|
|
ZTS
|
Healthcare |
William Blair |
Downgrade
|
Outperform
→
Mkt Perform
|
—
|
$32.0B
|
$74.39
|
+6.0%
|
+3.9%
|
-6.0%
|
+3.0%
|
+0.7%
|
-2.4%
|
|
IFF
|
Basic Materials |
Vertical Research |
Downgrade
|
Buy
→
Hold
|
$93
|
$22.5B
|
$88.07
|
-1.4%
|
-4.0%
|
+1.6%
|
-0.9%
|
-0.1%
|
-1.4%
|
|
GPN
|
Industrials |
Wolfe ResearchB |
Upgrade
|
Peer Perform
→
Outperform
|
$110
|
$21.7B
|
$87.48
|
+0.0%
|
+0.2%
|
-1.8%
|
+0.0%
|
-0.3%
|
+3.1%
|
|
TPG
|
Financial Services |
TD CowenA |
Upgrade
|
Hold
→
Buy
|
$64
|
$18.4B
|
$47.91
|
+1.7%
|
+1.3%
|
+1.0%
|
+0.8%
|
+2.4%
|
+0.6%
|
|
EXEL
|
Healthcare |
Leerink Partners |
Downgrade
|
Outperform
→
Market Perform
|
$52
|
$13.2B
|
$56.70
|
-6.7%
|
-7.9%
|
+3.6%
|
-2.1%
|
-3.1%
|
-1.9%
|
|
HUBS
|
Technology |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$12.8B
|
$250.21
|
-22.8%
|
-19.1%
|
+4.0%
|
+2.6%
|
+2.1%
|
-4.7%
|
|
HUBS
|
Technology |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
$220
|
$12.8B
|
$250.21
|
-22.8%
|
-19.1%
|
+4.0%
|
+2.6%
|
+2.1%
|
-4.7%
|
|
HUBS
|
Technology |
CapitalOne |
Downgrade
|
Overweight
→
Equal Weight
|
$206
|
$12.8B
|
$250.21
|
-22.8%
|
-19.1%
|
+4.0%
|
+2.6%
|
+2.1%
|
-4.7%
|
|
HUBS
|
Technology |
Stifel |
Downgrade
|
Buy
→
Hold
|
$200
|
$12.8B
|
$250.21
|
-22.8%
|
-19.1%
|
+4.0%
|
+2.6%
|
+2.1%
|
-4.7%
|
|
SNN
|
Healthcare |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$12.7B
|
$30.13
|
-1.3%
|
-1.5%
|
+1.4%
|
-0.1%
|
-0.2%
|
-0.6%
|
|
CRL
|
Healthcare |
JP MorganA |
Upgrade
|
Neutral
→
Overweight
|
$310
|
$12.6B
|
$260.72
|
+1.6%
|
+1.8%
|
+0.7%
|
+3.6%
|
+1.8%
|
+0.8%
|
|
PAYC
|
Technology |
BMO Capital Markets |
Reiterates
|
Market Perform
|
$208
|
$9.5B
|
$174.80
|
+21.8%
|
+23.6%
|
-0.5%
|
-0.7%
|
-0.6%
|
-0.4%
|
|
PODD
|
Healthcare |
Truist |
Downgrade
|
Buy
→
Hold
|
$153
|
$9.2B
|
$133.26
|
-1.8%
|
+4.5%
|
+1.3%
|
+1.2%
|
+1.3%
|
+0.2%
|